Logo image
Improvement in Lipids after Switch to Boosted Atazanavir or Darunavir in Children/Adolescents with Perinatally Acquired HIV on Older Protease Inhibitors: Results from the Pediatric HIV/AIDS Cohort Study
Journal article   Open access   Peer reviewed

Improvement in Lipids after Switch to Boosted Atazanavir or Darunavir in Children/Adolescents with Perinatally Acquired HIV on Older Protease Inhibitors: Results from the Pediatric HIV/AIDS Cohort Study

Jennifer Jao, Wendy Yu, Kunjal Patel, Tracie L. Miller, Brad Karalius, Mitchell E. Geffner, Linda A. DiMeglio, Ayesha Mirza, Janet S. Chen, Margarita Silio, …
HIV medicine, v 19(3), pp 175-183
21 Nov 2017
PMID: 29159965
url
https://europepmc.org/articles/pmc5821593View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Atazanavir Children Darunavir Lipids Longitudinal Perinatally HIV-infected

Metrics

20 Record Views
8 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Infectious Diseases
Logo image